Thyroid autoimmunity in patients with Familial Mediterranean Fever: Preliminary results

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 22, 2013, Pages 3024-3030

  Dikbas, Oguz ^a   Soy, M ^a   Bes, C ^a   Ankarali, H ^b   Bugdayci, G ^a   Zeyrek, A ^a  

^a ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

^b DUZCE UNIVERSITY   (Turkey)

Author keywords

Autoimmune; Familial mediterranean fever; Rheumatoid artritis; Thyroid

Indexed keywords

LIOTHYRONINE; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE THYROIDITIS; CONTROLLED STUDY; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; YOUNG ADULT;

ADULT; AUTOIMMUNITY; C-REACTIVE PROTEIN; CYTOKINES; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; MALE; THYROID GLAND; THYROID HORMONES; THYROIDITIS, AUTOIMMUNE; THYROTROPIN;

EID: 84891771398     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. OZEN S. Familial mediterranean fever: revisiting an ancient disease. Eur J Pediatr 2003; 162: 449-454.
2. HELLER H, SOHAR E, PRAS M. Ethnic distribution and amyloidosis in familial Mediterranean fever (FMF). Pathologia et Microbiologia 1961; 24: 718-723.
3. AKSENTIJEVICH I, CENTOLA M, DENG ZM, SOOD R, BALOW JE, WOOD G, ET AL. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 1997; 90: 797-807.
4. BERNOT A, CLEPET C, DASILVA C, DEVAUD C, PETIT JL, CALOUSTIAN C, CRUAUD C, SAMSON D, PULCINI F, WEISSENBACH J, HEILIG R, NOTANICOLA C, DOMINGO C, ROZENBAUM M, BENCHETRIT E, TOPALOGLU R, DEWALLE M, DROSS C, HADJARI P, DUPONT M, DEMAILLE J, TOUITOU I, SMAOUI N, NEDELEC B, MÉRY JP, CHAABOUNI H, DELPECH M, GRATEAU G. A candidate gene for familial Mediterranean fever. Nat Genet 1997; 17: 25-31.
5. BRAUN-FALCO M, RUZICKA T. Skin manifestations in autoinflammatory syndromes. J Dtsch Dermatol Ges 2011; 9: 232-245.
6. JACOBSON EM, TOMER Y. The genetic basis of thyroid Autoimmunity. Thyroid 2007; 17: 949-961.
7. GIANOUKAKIS AG, JENNINGS TA, KING CS, SHEEHAN CE, HOA N, HELDIN P, SMITH TJ. Hyaluronan accumulation in thyroid tissue: evidence for contributions from epithelial cells and fibroblasts. Endocrinology 2007; 148: 54-62.
8. SOY M, GULDIKEN S, ARIKAN E, ALTUN BU, TUGRUL A. Frequency of rheumatic diseases in patients with autoimmune thyroid disease. Rheumatol Int 2007; 27: 575-577.
9. LAZUROVA I, BENHATCHI K, ROVENSKY J, KOZAKOVA D, WAGNEROVA H, TAJTAKOVA M, SHOENFELD Y, MACEJOVA Z. Autoimmune thyroid disease and autoimmune rheumatic disorders a two-sided analysis. Ann Ny Acad Sci 2009; 1173: 211-216.
10. PELUSO R, LUPOLI GA, DEL PUENTE A, IERVOLINO S, BRUNER V, LUPOLI R, DI MINNO MN, FOGLIA F, SCARPA R, LUPOLI G. Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol 2011; 38: 1371-1377.
11. GULCAN E, GULCAN A, KOPLAY M, ALCELIK A, KORKMAZ U. Co-existence of Hashimoto's thyroiditis with familial Mediterranean fever: is there a pathophysiological association between the two diseases? Clin Exp Immunol 2009; 156: 373-376.
12. BAS F, KABATAS-ERYILMAZ S, GUNOZ H, DARENDELILER F, KUCUKEMRE B, BUNDAK R, SAKA N. Type 1 diabetes mellitus associated with autoimmune thyroid disease, celiac disease and familial Mediterranean fever: case report. Turkish J Pediatr 2009; 51: 183-186.
13. PETERSON S, SANGA A, EKLOF H, BUNGA B, TAUBE A, GEBRE-MEDHIN M, ROSLING H. Classification of thyroid size by palpation and ultrasonography in field surveys. Lancet 2000; 355: 106-110.
14. GRANEL B, SERRATRICE J, DODE C, GRATEAU G, DISDIER P, WEILLER PJ. Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations. Clin Exp Rheumatol 2007; 25: S93-S95.
15. KOCAK H, CAKAR N, HEKIMOGLU B, ATAKAN C, AKKOK N, UNAL S. The coexistence of familial Mediterranean fever and polyarteritis nodosa; report of a case. Pediatr Nephrol 1996; 10: 631-633.
16. OZEN S. Mutations/polymorphisms in a monogenetic autoinflammatory disease may be susceptibility markers for certain rheumatic diseases: lessons from the bedside for the benchside. Clin Exp Rheumatol 2009; 27: S29-S31.
17. NIELSEN CH, HEGEDUS L, RIENECK K, MOELLER AC, LESLIE RGQ, BENDTZEN K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th1) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin Exp Immunol 2007; 147: 287-295.
18. PAPIN S, CAZENEUVE C, DUQUESNOY P, JERU I, SAHALI D, AMSELEM S. The tumor necrosis factor alpha-dependent activation of the human Mediterranean fever (MEFV) promoter is mediated by a synergistic interaction between C/EBP beta and NF kappa B p65. J Biol Chem 2003; 278: 48839-48847.
19. ATABEK ME, PIRGON O, SERT A, ARSLAN U . Familial Mediterranean fever associated with type 1 diabetes - Association or coincidence? Endocrinologist 2006; 16: 133-135.
20. KALE N, ICEN M, AGAOGLU J, YAZICI I, TANIK O. Clustering of organ-specific autoimmunity: a case presentation of multiple sclerosis and connective tissue disorders. Neurol Sci 2008; 29: 471-475.
21. ERKEN E, OZER HTE, GUNESACAR R. Plasma interleukin-10 and interleukin-12 levels in patients with familial Mediterranean fever. Rheumatol Int 2006; 26: 862-864.
22. HAZNEDAROGLU S, OZTURK MA, SANCAK B, GOKER B, ONAT AM, BUKAN N, ERTENLI I, KIRAZ S, CALGUNERI M. Serum interleukin 17 and interleukin 18 levels in familial Mediterranean fever. Clin Exp Rheumatol 2005; 23: S77-S80.
23. ZHANG JA, ZHANG J, XU L, MAR H, WU XY. [Measurement of IL-12 and IL-18 in sera of patients with autoimmune thyroid disease]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2006; 22: 630-632.
24. BOSSOWSKI A, URBAN M. Serum levels of cytokines in children and adolescents with Graves' disease and non-toxic nodular goiter. J Pediatr Endocrinol Metab 2001; 14: 741-747.
25. CHEN K, WEI Y, SHARP GC, BRALEY-MULLEN H. Decreasing TNF-alpha results in less fibrosis and earlier resolution of granulomatous experimental autoimmune thyroiditis. J Leukoc Biol 2007; 81: 306-314.
26. TARHAN F, ORUK G, NIFLIOGLU O, OZER S. Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF alpha treatment. Rheumatol Int 2013; 33: 853-857.
27. KOGA T, TORIGOSHI T, MOTOKAWA S, MIYASHITA T, MAEDA Y, NAKAMURA M, KOMORI A, AIBA Y, UEMURA T, YATSUHASHI H, ISHIBASHI H, EGUCHI K, MIGITA K. Serum amyloid A-induced IL-6 production by rheumatoid synoviocytes. FEBS Letters 2008; 582: 579-585.
28. MIGITA K, KAWABE Y, TOMINAGA M, ORIGUCHI T, AOYAGI T, EGUCHI K. Serum amyloid A protein induces production of matrix metalloproteinases by human synovial fibroblasts. Lab Investig 1998; 78: 535-539.
29. PATEL H, FELLOWES R, COADE S, WOO P. Human serum amyloid A has cytokine-like properties. Scand J Immunol 1998; 48: 410-418.
30. ACOSTA-RODRIGUEZ EV, NAPOLITANI G, LANZAVECCHIA A, SALLUSTO F. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942-949.
31. MIGITA K, KOGA T, TORIGOSHI T, MOTOKAWA S, MAEDA Y, JIUCHI Y, IZUMI Y, MIYASHITA T, NAKAMURA M, KOMORI A, ISHIBASHI H. Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes. Clin Exp Immunol 2010; 162: 244-250.
32. FIGUEROA-VEGA N, ALFONSO-PEREZ M, BENEDICTO I, SANCHEZ-MADRID F, GONZALEZ-AMARO R, MARAZUELA M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocr Metab 2010; 95: 953-962.
33. ASAKAWA H, MIYAGAWA J, KOBAYASHI T, HANAFUSA T, KUWAJIMA M, MATSUZAWA Y. Effects of interleukin-1 beta on scanning electron microscopic appearance and thyroid peroxidase content of human thyrocytes in monolayer culture. Immunopharmacology 1996; 34: 131-137.
34. WEIJL NI, VANDERHARST D, BRAND A, KOOY Y, VANLUXEMBURG S, SCHRODER J, LENTJES E, VAN ROOD JJ, CLETON FJ, OSANTO S. Hypothyroidism during immunotherapy with interleukin-2 Is associated with antithyroid antibodies and response to treatment. J Clin Oncol 1993; 11: 1376-1383.
35. YILDIZ L, KEFELI M, KOSE B, BARIS S. Amyloid goiter: two cases and a review of the literature. Ann Saudi Med 2009; 29: 138-141.
36. OZDEMIR BH, AKMAN B, OZDEMIR FN. Amyloid goiter in Familial Mediterranean Fever (FMF): a clinicopathologic study of 10 cases. Ren Fail 2001; 23: 659-667.
37. BHOLE VM, CHOI HK, BURNS LC, KELLET CV, LACAILLE DV, GLADMAN DD, DUTZ JP. Differences in body mass index among individuals with PsA, psoriasis, RA and the general population. Rheumatology 2012; 51: 552-556.
38. PANOULAS VF, METSIOS GS, PACE AV, JOHN H, TREHARNE GJ, BANKS MJ, KITAS JD. Hypertension in rheumatoid arthritis. Rheumatology 2008; 47: 1286-1298.
39. STAVROPOULOS-KALINOGLOU A, METSIOS GS, KOUTEDAKIS Y, NEVILL AM, DOUGLAS KM, JAMURTAS A, VAN ZANTEN JJ, LABIB M, KITAS GD. Redefining overweight and obesity in rheumatoid arthritis patients. Ann Rheum Dis 2007; 66: 1316-1321.
40. PRUMMEL MF, STRIEDER T, WIERSINGA WM. The environment and autoimmune thyroid diseases. Eur J Endocrinol 2004; 150: 605-618.